Sort
50,496 grants matching “lung cancer”
Project 1: Tobacco Retailer Density, Smoking and Tobacco-Related Disease
$474,645Kurt M. Ribisl · Univ Of North Carolina Chapel Hill · P01 · FY2022 · CA
Lung Resident Mesenchymal Cells in the Pre-Metastatic Niche Formation
$474,621Guangwen Ren · Jackson Laboratory · R01 · FY2023 · CA
Lung Resident Mesenchymal Cells in the Pre-Metastatic Niche Formation
$474,620Guangwen Ren · Jackson Laboratory · R01 · FY2022 · CA
Translating phospholipase activatable fluorophores for the sensitive detection of non-small cell lung cancer
$474,577Edward J Delikatny · University Of Pennsylvania · R01 · FY2022 · CA
Novel markers of exposure and pathways of response to Chromium
$474,512Bernardo Lemos · Harvard School Of Public Health · R01 · FY2020 · ES
The Early Detection Research Network: Biomarker Referen*
$474,500David S Chia · University Of California Los Angeles · U24 · FY2007 · CA
HVEM-BTLA system in inflammation
$474,500Carl F Ware · La Jolla Institute For Immunology · R01 · FY2007 · AI
Aerosolized microbots as a platform for targeted lung therapy
$474,497David Wm Marr · Colorado School Of Mines · R01 · FY2025 · EB
Geisinger Clinical Oncology Program
$474,493Geisinger Medical Center · U10 · FY2004 · CA
Community Outreach and Engagement
$474,319Erika S Trapl · Case Western Reserve University · P30 · FY2025 · CA
Targeting vulnerabilities in copper metabolism in the development of cancer therapies
$474,299Michael J Petris · University Of Missouri-Columbia · R01 · FY2023 · CA
Modulating systemic pro-oncogenic effects of focal image-guided tumor ablation
$474,276Muneeb Ahmed · Beth Israel Deaconess Medical Center · R01 · FY2017 · CA
UDP-GLUCURONOSYLTRANSFERASE GENOTYPE AND CANCER RISK
$474,247Philip Lazarus · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2007 · DE
MEG3 deletion drives lung tumorigenesis due to environmental nickel exposure
$474,232Max Costa · New York University School Of Medicine · R01 · FY2019 · CA
Discovery of novel cytotoxic natural products from marine sponges and fungi
$474,174Phil Crews · University Of California Santa Cruz · R01 · FY2010 · CA
Screening and Risk Biomarkers for Ovarian Cancer in EPIC Specimens
$474,155Daniel William Cramer · Brigham And Women'S Hospital · R01 · FY2014 · CA
Building Family Caregiver Skills Using a Simulation-Based Intervention for Care of Patients with Cancer
$474,143Susan Mazanec · Case Western Reserve University · R37 · FY2022 · CA
Young Smoker's Reactions to Genetic Risk for Lung Cancer
$474,128Isaac M Lipkus · Duke University · R01 · FY2007 · CA
The development of novel radiation-sensitizer based on ultra-small carbon dots
$474,089Zibo Li · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA
Targeting PGC1β/PPARγ axis for overcoming acquired resistant to third generation EGFR-TKIs
$474,087Shi-Yong Sun · Emory University · R01 · FY2024 · CA
Targeting lung tumors expressing mutant p53 with oncolytic viruses and suicide genes
$474,061Sumitra Deb · Virginia Commonwealth University · R01 · FY2021 · CA
Exploring Collateral Lethality for Development of Cancer Therapeutics
$474,054Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Exploring Collateral Lethality for Development of Cancer Therapeutics
$474,053Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Cancer Recurrence: Detection in Administrative Data, Incidence, and Costs
$474,024Michael James Hassett · Dana-Farber Cancer Inst · R01 · FY2015 · CA
Development Of Drugs Acting At Adenosine Receptors
$473,998Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK